Insys Therapeutics Inc. (fka INSYQ)

[terry hallinan]

INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy in Pediatric Patients

https://tinyurl.com/yderokzj

Kindly forgive a repeat of the shortened "news" headline above but there is a very important difference in this trial of a synthetic drug compared to the previous trial of a biologic that is used by nearly all medical "pot" stocks.

Synthetics are nearly always preferred to biologics when they can be sythesized because of uniformity and purity.

Is there a guarantee the children will do better with a synthetic drug?

- No. Especially in the case of drugs like the cannabinoids that are still extremely difficult to study, one cannot know in advance that a "contaminant" is not responsible for some or all of any beneficial effects.

There is a great deal of speculation and some tantalizing evidence that many drugs aside from the THC "joy juice" can be synthesized.

This could easily put INSY at the head class in my opinion.

Best, Terry